Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
KDMF
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Jai Radhe Sales is your partner for all your sourcing needs.
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
CEP/COS
JDMF
NDC
KDMF
ASMF
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
GDUFA
DMF Review : Complete
Rev. Date : 2022-04-15
Pay. Date : 2022-03-08
DMF Number : 36834
Submission : 2022-03-16
Status :
Type : II
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
GDUFA
DMF Review : Complete
Rev. Date : 2013-07-23
Pay. Date : 2013-03-06
DMF Number : 24939
Submission : 2011-05-06
Status :
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-23
Pay. Date : 2012-11-08
DMF Number : 21827
Submission : 2008-07-28
Status :
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE
USFDA APPLICATION NUMBER - 21427
DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE
USFDA APPLICATION NUMBER - 21427
DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE
USFDA APPLICATION NUMBER - 21427
Related Excipient Companies
Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Coating Systems & Additives
Controlled & Modified Release
Solubilizers
Disintegrants & Superdisintegrants
Direct Compression
Thickeners and Stabilizers
Granulation
Taste Masking
Topical
Chewable & Orodispersible Aids
Parenteral
Lubricants & Glidants
Film Formers & Plasticizers
Co-Processed Excipients
Empty Capsules
Emulsifying Agents
API Stability Enhancers
Rheology Modifiers
Coloring Agents
Surfactant & Foaming Agents
Vegetarian Capsules
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory FDF Prices
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class B
Dosage Form : Capsules
Dosage Strength : 30mg
Price Per Pack (Euro) : 10.46
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
RX/OTC/DISCN :
Dosage Form : Gastro-Resistant Hard Capsules
Dosage Strength : 30 mg
Price Per Pack (Euro) : 8.27
Published in :
Country : Italy
RX/OTC/DISCN :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class B
Dosage Form : Capsules
Dosage Strength : 60mg
Price Per Pack (Euro) : 18.41
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class B
Dosage Form : Kaps
Dosage Strength : 60mg
Price Per Pack (Euro) : 9.72
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class B
Dosage Form : Kaps
Dosage Strength : 60mg
Price Per Pack (Euro) : 53.75
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
RX/OTC/DISCN :
Dosage Form : Gastro-Resistant Hard Capsules
Dosage Strength : 60 mg
Price Per Pack (Euro) : 16.51
Published in :
Country : Italy
RX/OTC/DISCN :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
20 Jun 2024
Reply
17 Apr 2024
Reply
03 Feb 2024
Reply
01 May 2023
Reply
15 Sep 2022
Reply
01 Jul 2022
Reply
24 Jun 2022
Reply
30 Mar 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
BioAnalytical Methods
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Analytical Methods
ABOUT THIS PAGE
48
PharmaCompass offers a list of Duloxetine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Duloxetine manufacturer or Duloxetine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Duloxetine manufacturer or Duloxetine supplier.
PharmaCompass also assists you with knowing the Duloxetine API Price utilized in the formulation of products. Duloxetine API Price is not always fixed or binding as the Duloxetine Price is obtained through a variety of data sources. The Duloxetine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH], including repackagers and relabelers. The FDA regulates DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] supplier is an individual or a company that provides DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] active pharmaceutical ingredient (API) or DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] finished formulations upon request. The DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] suppliers may include DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] API manufacturers, exporters, distributors and traders.
click here to find a list of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] DMF (Drug Master File) is a document detailing the whole manufacturing process of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] active pharmaceutical ingredient (API) in detail. Different forms of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] DMFs exist exist since differing nations have different regulations, such as DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] DMF submitted to regulatory agencies in the US is known as a USDMF. DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] USDMF includes data on DULOXETINE HYDROCHLORIDE [EP MONOGRAPH]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] Drug Master File in Japan (DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] JDMF) empowers DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] JDMF during the approval evaluation for pharmaceutical products. At the time of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] Drug Master File in Korea (DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH]. The MFDS reviews the DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] KDMF as part of the drug registration process and uses the information provided in the DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] KDMF to evaluate the safety and efficacy of the drug.
After submitting a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] suppliers with KDMF on PharmaCompass.
A DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CEP of the European Pharmacopoeia monograph is often referred to as a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] Certificate of Suitability (COS). The purpose of a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] to their clients by showing that a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CEP has been issued for it. The manufacturer submits a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CEP (COS) as part of the market authorization procedure, and it takes on the role of a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CEP holder for the record. Additionally, the data presented in the DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] DMF.
A DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] suppliers with CEP (COS) on PharmaCompass.
A DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] written confirmation (DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] WC) is an official document issued by a regulatory agency to a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] manufacturer, verifying that the manufacturing facility of a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] APIs or DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] finished pharmaceutical products to another nation, regulatory agencies frequently require a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] WC (written confirmation) as part of the regulatory process.
click here to find a list of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] suppliers with NDC on PharmaCompass.
DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] GMP manufacturer or DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] GMP API supplier for your needs.
A DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CoA (Certificate of Analysis) is a formal document that attests to DULOXETINE HYDROCHLORIDE [EP MONOGRAPH]'s compliance with DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] specifications and serves as a tool for batch-level quality control.
DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CoA mostly includes findings from lab analyses of a specific batch. For each DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] may be tested according to a variety of international standards, such as European Pharmacopoeia (DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] EP), DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DULOXETINE HYDROCHLORIDE [EP MONOGRAPH] USP).
Comment (33)
